world1 outlet covering this

FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients

First publishedJun 2, 13:03 UTC

Last updatedJul 12, 12:32 UTC · 13m ago

↻

each logo = when that outlet publishedlast updated on Braven

Story signals

How strong is this topic?

High significance means broad impact or urgency. Source trust reflects the average authority of outlets covering the story.

Significance5.3

Weighted from impact, urgency, coverage breadth, and topic sensitivity.

Source trust10.0

Average reliability level of outlets included in this topic.

Outlets1

Independent sources contributing to this topic cluster.

More outlets usually means a more confirmed developing story.

The report

The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more efficiently by making greater use of existing scientific and regulatory knowledge.

Read the full report at FDA ↗

Related in the knowledge graph

organizationDrug Administration organizationFDA organizationFDA Issues Draft Guidance organizationGene Therapies organizationHelp Accelerate Cell organizationPatients. The U.S. Food

Sources (1)

Avg source rating 10.0/10

FDA10